Skip to main content
MESOBLAST LTD logo

MESOBLAST LTD — Investor Relations & Filings

Ticker · MESO ISIN · US5907171046 ASX Manufacturing
Open in API
Filings indexed 2,013 across all filing types
Latest filing 2024-05-09 Director's Dealing
Country US United States of America
Listing ASX MESO

About MESOBLAST LTD

https://www.mesoblast.com/

Mesoblast is a regenerative medicine company that develops allogeneic (off-the-shelf) cellular medicines for severe and life-threatening inflammatory conditions. The company utilizes its proprietary mesenchymal lineage cell (MSC) technology platform to create treatments for inflammatory ailments, cardiovascular disease, and chronic back pain. The technology sources rare MSCs from the bone marrow of healthy adult donors, which are then expanded using proprietary processes for industrial-scale manufacturing. A key feature of these cells is their ability to be administered without donor-recipient matching or immune suppression. The therapeutic candidates are designed to respond to tissue damage by secreting mediators that promote tissue repair and modulate immune responses. The company's late-stage portfolio includes remestemcel-L for acute graft versus host disease (GVHD) and acute respiratory distress syndrome (ARDS), REVASCOR® for advanced chronic heart failure, and MPC-06-ID for chronic low back pain.

Recent filings

Filing Released Lang Actions
Appendix 3Y for Eric Rose 3 pages 242.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details the change in securities holdings of a company director, including the number of shares/options held before and after the change, the nature of the interest, and transaction details. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document length is 4120 characters, which is consistent with a detailed notice rather than a brief announcement. There is no indication that this is an annual report, audit report, or any other category. Therefore, the correct classification is Director's Dealing (DIRS).
2024-05-09 English
AMENDMENT TO FORM SC 13G
Major Shareholding Notification
2024-05-03 English
6-K
Regulatory Filings
2024-05-03 English
Appendix 3Y for Eric Rose 3 pages 242.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a change in a director's relevant interests in securities, including the number of securities held before and after the change, the nature of the change, and the value of the transaction. The document is focused on reporting insider transactions by a company director. It does not contain financial statements, earnings data, or management discussion. The content matches the definition of a Director's Dealing report, which is a report of personal share transactions by company directors and executives (insider trades). The document length is 4318 characters, which is consistent with a detailed insider transaction notice rather than a full financial report or announcement. Therefore, the correct classification is DIRS (Director's Dealing).
2024-05-02 English
Change in substantial holding 4 pages 172.0KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001, Section 671B, titled 'Notice of change of interests of substantial holder'. It details changes in voting power and relevant interests of a substantial shareholder in Mesoblast Limited, including dates, nature of changes, and number of securities affected. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category 'Major Shareholding Notification'. The document length is 9348 characters, which is substantive and contains detailed data, not just an announcement or certification. Therefore, it fits the 'MRQ' category.
2024-05-01 English
6-K
Regulatory Filings
2024-05-01 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.